Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
GR.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
GR.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
GR.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
EG.1.2NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
EG.1.2NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
EG.1.2NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XBB.1.16.21NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XBB.1.16.21NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XBB.1.16.21NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.568NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.568NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.568NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.13 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.13 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.13 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.372NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.372NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.372NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.634NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.634NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.634NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.37.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.37.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.37.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-17590.1China
B.1.630NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.630NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.630NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.360NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.360NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.360NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.578NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.578NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.578NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.544NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.544NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.544NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.448NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.448NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.448NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.425NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.425NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.425NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.354NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.354NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.354NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.503NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.503NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.503NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.31NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.31NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used